Electrical Impedance Spectroscopy for Skin Cancer Detection

Important results from the project

Nevisense is the world´s first diagnostic support tool for non-visual detection of malignant melanoma. The goal for the project has been achieved by designing, producing and testing a miniaturized prototype with corresponding performance as Nevisense. Both phantom test and in-vivo test on skin show results comparable with Nevisense but at a much smaller form factor and with far less power consumption.

Expected long term effects

The outcome of the project is a prototype of a miniaturized Nevisense, a pen-like device for measurement of skin impedance. The prototype has been evaluated with electrical phantoms and in-vivo testing on skin. All tests show a performance comparable to the existing Nevisense but in a considerable smaller form factor with less power consumption. This will enable a modular concept that delivers Nevisense capability in an easy-to use form factor with improved integration to the physician workflow.

Approach and implementation

The project is conducted in cooperation between SciBase and the ICS-group at KTH. The cooperation has been successful and contributed to many synergy effects. SciBase has contributed with their clinical competence while the ICS-group have contributed with their unique competence within design of miniaturized electronics. The project has followed the time schedule and the test results are above expectation for all involved.